CS
RVMDW icon

Clear Street’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Clear Street’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$4 – 712
2025
Q1 		$4 Buy
+100
New +$12 ﹤0.01% 570

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
SCM
Soros Capital Management New York $230M AUM 83.9% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clear Street's RVMDW Position: Q2 2025 in Review

Clear Street sold out of Revolution Medicines Inc Warrant (RVMDW) in Q2 2025, closing a stake of 100 shares — an estimated $4 sold.

Clear Street first reported a position in RVMDW in Q1 2025 and held it in 1 quarter. The position peaked at $4 in Q1 2025. 23 funds tracked by Wall St. Rank hold RVMDW as of Q2 2025.

  • Clear Street reported no remaining Revolution Medicines Inc Warrant position as of Q2 2025 after selling out during the quarter.
  • Clear Street sold 100 Revolution Medicines Inc Warrant shares in Q2 2025, an estimated $4.
  • Clear Street first reported a position in Revolution Medicines Inc Warrant in Q1 2025 and held it in 1 quarter.
  • Clear Street's Revolution Medicines Inc Warrant position peaked at $4 in Q1 2025.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2025.

Based on Clear Street's 13F filing for Q2 2025, filed 13 Aug 2025.